(Q33632883)

28 July 2017

title

Coated dosage forms for colon-specific drug delivery (English)

1 reference

28 July 2017

1 reference

Leopold CS

1

1 reference

28 July 2017

publication date

1 May 1999

1 reference

Pharmaceutical science & technology today

28 July 2017

published in

1 reference

28 July 2017

volume

2

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

197-204

1 reference

Measurement of gastrointestinal pH profiles in normal ambulant human subjects

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

An oral preparation to release drugs in the human colon

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Experience with Eudragit-S-coated mesalamine (Asacol) in inflammatory bowel disease. An open study.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Colonic bicarbonate output as a test of disease activity in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Very low intraluminal colonic pH in patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Scintigraphic evaluation of a new capsule-type colon specific drug delivery system in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

An organic acid-induced sigmoidal release system for oral controlled-release preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Calcium alginate beads as core carriers of 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Design and preparation of pulsatile release tablet as a new oral drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

A new approach to the oral administration of insulin and other peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Biodegradable azopolymer coating for oral delivery of peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Hydrogels for site-specific oral drug delivery: synthesis and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Design of microencapsulated chitosan microspheres for colonic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Crosslinked dextran--a new capsule material for colon targeting of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Pectin/ethylcellulose film coating formulations for colonic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

Importance of dissolution process on systemic availability of drugs delivered by colon delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900151-0

7 January 2021

10.1016/S1461-5347(99)00151-0

Identifiers

DOI

1 reference

28 July 2017

1 reference